Mediconflex Ltd Filleted Accounts Cover
Mediconflex Ltd
Company No. 14078330
Unaudited Accounts
30 April 2024
Mediconflex Ltd Balance Sheet Registrar
at
30 April 2024
Company No.
14078330
2024
2023
£
£
Fixed assets
33,11239,859
Current assets
40,74912,495
Creditors: Amounts falling due within one year
(7,478)
(2,570)
Net current assets
33,2719,925
Total assets less current liabilities
66,38349,784
Accruals and deferred income
(1,186)
(1,066)
65,19748,718
Capital and reserves
65,197
48,718
NOTES TO THE ACCOUNTS
1
Basis of preparation
These accounts have been prepared in accordance with the micro-entity provisions of the small companies regime.
2
Employees
2024
2023
Number
Number
The average monthly number of employees (including directors) during the year was:
2
2
3
Advances and credits to directors
2024
£
At 1 May 2023
7,095
Advanced in the period
6,113
Amounts repaid in the period
(9,063)
At 30 April 2024
4,145
4
General information
Mediconflex Ltd is a private company limited by shares and incorporated in England and Wales.
Its registered number is:
14078330
Its registered office is:
Office10 Workspace Penarth
Albert Road
Penarth
CF64 1FD
For the year ended 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A) of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
The accounts were approved by the board of directors on 09 December 2024 and signed on its behalf by:
Darren Cooper - Director
Mediconflex Ltd1407833030 April 202401 May 2023false09 December 2024BTCSoftware AP Solution 2024 11.1.0811.1.08The principal activity of the company during the year under review was of pharmaceutical industry consultants. 140783302023-05-012024-04-30140783302024-04-30140783302023-04-3014078330core:WithinOneYear2024-04-3014078330core:WithinOneYear2023-04-30140783302022-04-292023-04-30140783302023-05-0114078330countries:UnitedKingdom2023-05-012024-04-3014078330bus:RegisteredOffice2023-05-012024-04-3014078330bus:Micro-entities2023-05-012024-04-3014078330bus:FullAccounts2023-05-012024-04-3014078330bus:AuditExempt-NoAccountantsReport2023-05-012024-04-3014078330bus:Director12023-05-012024-04-3014078330bus:PrivateLimitedCompanyLtd2023-05-012024-04-30iso4217:GBPxbrli:pure